Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × OTHER × Tumor Response Rate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3133 Neoplasms 2453 Prostatic Neoplasms 1420 Colorectal Neoplasms 1121 Lung Neoplasms 1047 Motor Activity 683 Head and Neck Neoplasms 562 Pancreatic Neoplasms 541 Colonic Neoplasms 517 Carcinoma, Non-Small-Cell Lung 504 Uterine Cervical Neoplasms 497 Carcinoma, Hepatocellular 494 Rectal Neoplasms 461 Stomach Neoplasms 437 Brain Neoplasms 385 Anxiety Disorders 359 Ovarian Neoplasms 357 Pain 332 Polycystic Ovary Syndrome 305 Esophageal Neoplasms 305 Neoplasm Metastasis 299 Urinary Bladder Neoplasms 285 Fatigue 284 Melanoma 269 Precursor Cell Lymphoblastic Leukemia-Lymphoma 267 Multiple Myeloma 255 Depression 253 Lymphoma 238 Endometrial Neoplasms 232 Hematologic Neoplasms 218

Interventions

Sirtuins 1 Radiotherapy, Conformal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03910140 2019-04-10

TILA-TACE in Treatment of Hepatocellular Carcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Unknown

Tumor Response Rate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡